Home > Category > Signaling Pathways > Metabolism > Renin > Aliskiren Hemifumarate (Synonyms: CGP 60536 hemifumarate; CGP60536B hemifumarate; SPP 100 hemifumarate)

Aliskiren Hemifumarate (Synonyms: CGP 60536 hemifumarate; CGP60536B hemifumarate; SPP 100 hemifumarate)

ChemLeader 98+%
Catalog No:CL3027A CAS No.:173334-58-2 MDLNo:MFCD10566724 Formula:C34H57N3O10 MW:667.83
Size Availability Price(USD) VIP Price (USD) Quantity

There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Chemical safety data sheet(MSDS)

Download MSDS
  • Product Overview
  • Related documents
  • Product details
  • Related literature
Product Overview
Product Name Aliskiren Hemifumarate (Synonyms: CGP 60536 hemifumarate; CGP60536B hemifumarate; SPP 100 hemifumarate)
CAS173334-58-2
FormulaC34H57N3O10
MW667.83
MDLMFCD10566724
Appearance White to off-white powder
Storage condition4°C, sealed storage, away from moisture
Product details

Aliskiren hemifumarate (CGP 60536; CGP60536B; SPP 100) is an orally active, selective renin inhibitor with an IC50 of 1.5 nM. It is utilized in research pertaining to hypertension, cardiovascular diseases, and cancer cachexia.As a direct renin inhibitor, aliskiren targets the renin-angiotensin-aldosterone system (RAAS), a key pathway in blood pressure regulation. Its role in hypertension management is significant, offering an alternative to traditional antihypertensive medications. Additionally, aliskiren's potential impact on cardiovascular health and cancer cachexia is under investigation, highlighting its broad research applications.

Related
Sorry, no related items
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays